Skip to main content
. 2019 Nov 22;5(11):e02787. doi: 10.1016/j.heliyon.2019.e02787

Table 7.

Benefits and Risks of Complementary Therapy compared to standard control group.

Use of complementary therapy
Nulliparous (All labourers, spontaneous & induced)
Multiparous (All labourers, spontaneous & induced)
Benefits 20% less likely to require epidural
Shorter labour (1.6 h)
36% less likely to require oxytocin augmentation for labour
Reduced average blood loss at delivery (regardless of mode of delivery)
Risks 5 times more likely to have significant perineal trauma
No Difference
IOL, mode of delivery, major PPH, shoulder dystocia, perineal trauma and neonatal admission rates
No clear advantage at reducing chances of induction/oxytocin induction, epidural rates, length of labour, need for emergency caesarean section nor blood loss at delivery, shoulder dystocia and neonatal admission rates
Use of complementary therapy
Nulliparous
Spontaneous labours
Induced labours
Benefits 32% less likely to require epidural 57% less likely to need oxytocin augmentation for labour
Shorter labour (1.7hours)
27% less likely to require oxytocin augmentation for labour
30% more likely to achieve a vaginal delivery without intervention
Risks - 24% less likely to achieve a vaginal delivery without intervention
80% more likely to have an emergency caesarean section
No Difference
Gestational age at delivery, instrumental delivery or EMCS, blood loss, major PPH, neonatal birth weight, perineal trauma, shoulder dystocia and neonatal admission rates
Epidural rate, length of labour, use of oxytocin for IOL, Gestational age at delivery, instrumental delivery, blood loss, major PPH, neonatal birth weight, perineal trauma, shoulder dystocia and neonatal admission rates
Use of complementary therapy
Multiparous
Spontaneous labours
Induced labours
Benefits No apparent benefits No apparent benefits
Risks 11 times more likely to have an emergency caesarean section
No Difference No clear advantage on reducing epidural rates, length of labour, need for oxytocin augmentation. Gestational age at delivery, mode of delivery, blood loss, major PPH, neonatal birth weight, perineal trauma, shoulder dystocia and neonatal admission rates No clear advantage on reducing need for oxytocin augmentation, epidural rates, length of labour and instrumental delivery
Gestational age at delivery, blood loss, major PPH, neonatal birth weight, perineal trauma, shoulder dystocia and neonatal admission rates